ChemPartner
22.12.2023 22:02:41 CET | ACCESS Newswire | Press release
Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs
SHANGHAI, CHINA / ACCESSWIRE / December 22, 2023 / ChemPartner, a global leader in drug discovery and development services, today announced the launch of its long-awaited Biology Database. This innovative platform serves as a centralized hub, empowering ChemPartner's clientele with seamless access to a wealth of information on the organization's cutting-edge preclinical platforms. The database includes 800+ tumor models, 30+ cancer types, 20,000 genes, 2,300+ pathways, 1,800 SoC data from literature (500 internal), and 30+ analytic modules.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Screenshot of the online Biology Database from ChemPartner
ChemPartner's renowned biology and pharmacology department, known for its vanguard oncology, immunology, CNS, and metabolic services, has curated an extensive collection of in vitro and in vivo models. The database boasts over 2,000 biochemistry assays, 800 cell lines, 500 patient-derived xenograft (PDX) models, 350 cell-derived xenograft (CDX) models, and 50 syngeneic models. Each model is meticulously characterized with comprehensive data encompassing genomics, pharmacology, histopathology, and relevant clinical information.
Cell Line Models - ChemPartner Biology Database
To ensure a smooth and efficient rollout of this substantial volume of data, the database will be introduced in stages. We are delighted to announce that the first stage, featuring cell line data, is now live on https://database.chempartner.com. Subsequent stages will include CDX, syngeneic, and PDX models, followed by biochemistry data.
The Biology Database, a flagship online collaborative platform, prominently features the Tumor Model Database. This revolutionary resource offers an array of features, including:
- Unified Data Hub: Integration of dispersed tumor model data into a centralized database for efficient management and retrieval, simplifying user access to diverse tumor models.
- Detailed Annotations: Each model is accompanied by intricate annotations including genomics, pathology, and pharmacology data, enabling rapid understanding of model characteristics and suitability for specific research needs.
- Rapid Search and Filtering: Multidimensional search and filtering capabilities empower researchers to swiftly locate models based on cancer type, genomic features, drug sensitivity, and more.
- Data Analysis and Mining: Robust tools facilitate tasks like drug mechanism analysis and biomarker discovery through differential gene expression and drug sensitivity analyses, supporting informed research decisions.
- Data Visualization: Intuitive charts, statistics, and visualization tools present complex data clearly and concisely, aiding in model selection and analysis.
Dr. Lilly Xu, President of Shanghai ChemPartner, expressed enthusiasm about the launch saying, "We are excited to provide our customers with access to this powerful new resource. This comprehensive database will make it easier for our customers to find and use the right models for their research, propelling drug development towards new heights with better precision, efficacy, and efficiency."
-
About ChemPartner
ChemPartner is a leading global CRO and CDMO providing drug discovery, development, and manufacturing services to the pharmaceutical and biotechnology industries. With a team of over 2,000 scientists across multiple countries, ChemPartner offers a comprehensive range of services including preclinical pharmacology, toxicology, drug metabolism and pharmacokinetics, chemistry development, and biologics development. For more information, please visit https://chempartner.com and connect with ChemPartner on LinkedIn, X, and YouTube.
Contact Information
Sarah Stapleton
Marketing Director
news@chempartner.com
6504199974
Related Images
|
SOURCE: ChemPartner
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Steelcase Names Proven Growth Leader Irene Tasi as President9.9.2026 21:00:00 CEST | Press release
Experienced commercial and innovative leader will guide the Steelcase business as the company builds on its design leadership, dealer network and customer-focused strategy. GRAND RAPIDS, MI / ACCESS Newswire / September 9, 2026 / Steelcase today announced Irene Tasi has been named president of Steelcase and will lead the business effective September 14, 2026. Tasi brings more than 25 years of executive leadership experience with a track record leading complex businesses through growth, portfolio development, commercial execution, and organizational change. Her background includes full P&L responsibility, enterprise strategy, innovation, and sales and channel leadership. She will report to Jeff Lorenger, Chairman, President and Chief Executive Officer, HNI Corporation. "Irene brings a combination of commercial leadership, product innovation, operating discipline, and customer focus that makes her exceptionally well-suited to lead Steelcase," said Lorenger. "She has led businesses where
Global Study: Nursing Shortages Require Workforce Policy Solutions, Not Recruitment Campaigns Alone9.9.2026 15:01:00 CEST | Press release
Why people choose nursing, and why they leave, comes down to the same factors PHILADELPHIA, PA / ACCESS Newswire / September 9, 2026 / The global nursing shortage cannot be solved simply by encouraging more people to enter the profession, according to a new evidence brief from the Global Nursing Workforce Centre (GNWC), a joint initiative of the International Council of Nurses (ICN) and TruMerit®. Drawing on research from 42 countries, the brief, The Attractiveness of Nursing for Prospective and Current Nursing Students, finds that the factors influencing people to choose nursing are often the same ones that determine whether they stay. Working conditions, compensation, professional respect, career development opportunities, workplace experiences, and the ability to provide quality care all shape nursing attractiveness to current nurses as well as potential recruits. The findings suggest that countries seeking to strengthen their nursing workforce must focus not only on recruitment, bu
Leggett Dynamics Showcases Award-Finalist Innovations at Automotive News Congress in Detroit9.9.2026 13:00:00 CEST | Press release
Mid-Class Massage System & Smart Brushless Motor Named Finalist For 2026 Automotive News PACE & PACE Pilot Awards DETROIT, MI / ACCESS Newswire / September 9, 2026 / Leggett Dynamics will showcase two next-generation comfort and motion technologies at the 50th Automotive News Congress, September 29-30 in Detroit, Michigan. Both innovations have been named finalists for 2026 Automotive News awards, recognizing the company's commitment to developing innovative comfort and motion solutions that address the evolving needs of automakers and consumers. Leggett Dynamics' Mid-Class Massage System has been named a finalist for the 2026 Automotive News PACE Award, while the company's Smart Brushless Motor has been named a finalist for the 2026 Automotive News PACE Pilot Award. During the 50th Automotive News Congress event, attendees are invited to visit Leggett Dynamics' showcase to explore both technologies firsthand and connect with the team behind their development. The showcase will offer a
IXOPAY Launches Agentic Suite to Help Merchants Support Agentic Commerce and Automate Payment Workflows9.9.2026 12:00:00 CEST | Press release
Flexible, Protocol-Agnostic Suite Helps Merchants Support Agentic Commerce, Preserve Transaction Context and Accelerate Payment Workflows With Secure AI Access DALLAS, TX / ACCESS Newswire / September 9, 2026 / IXOPAY, a leader in payment infrastructure enabling fluid commerce, today announced the launch of the IXOPAY Agentic Suite, a flexible set of tools designed to help merchants prepare for both new agentic buying experiences and the growing role of AI in payment operations. The suite includes Payment Agent, which provides protocol-agnostic connectivity between agentic shopping experiences and existing payment infrastructure; Universal Tokens to preserve transaction context so merchants can confidently participate in agentic commerce while reducing risk; and Model Context Protocol (MCP) Server, which gives approved AI assistants secure and governed access to payment and tokenization capabilities. Together, the suite gives merchants a faster and more flexible way to launch new buyin
Learnis: A New International Network for Transformative Education is Born.8.9.2026 23:05:00 CEST | Press release
Three groups of companies from Italy, Spain and the United States unite in a new corporate network structure, strong of a 20-year shared method that converges under one masterbrand - Learnis, Your transformative education. MILAN, IT / ACCESS Newswire / September 8, 2026 / A new corporate structure brings together Genio Net, the Italian business network directed by Massimo De Donno; Crecimiento Personal SL, the company headed by Giacomo Navone as the franchisor of the Spanish network; and Genius in 21 Days LLC, founded in the United States by Stephanie Turconi and Cosimo Intermite. Across the three countries, the group runs more than 50 learning centers, working with certified instructors and tutors, and reaching over 5,000 participants each year with its immersive courses, training paths and publications, with a focus on personalized study methods and learning. The group has chosen to introduce itself publicly on September 8, 2026, the International Literacy Day. Promoted by UNESCO to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom